←
Anton Henssen1,461 posts
Anton Henssen avatar

Anton Henssen

@anton_gh

Head of preclinical pediatric cancer research @ChariteBerlin ECRC @MDC_Berlin. Extrachromosomal DNA (ecDNA) in cancer. Cancer Grand Challenges Team eDyNAmiC

◷ Joined December 2011
Anton Henssen avatar
Anton Henssen@anton_gh·11 Jan 2024

Glad to see this work led by @_YiBei online @CD_AACR 🔥🔥! Thank you to all the co-authors (esp. Jan Dörr) and @imsmd for the great editorial guidance !!👇🏻👇🏻

Now online in @CD_AACR: Passenger Gene Co-Amplifications Create Collateral Therapeutic Vulnerabilities in Cancer - by @_YiBei, @anton_gh, Jan Dörr, and colleagues doi.org/10.1158/2159-8290.CD… @DKTK_ @ChariteBerlin @MDC_Berlin @berlinnovation

Post attachment
Cancer Grand Challenges avatar
⟳ Anton Henssen retweeted
Cancer Grand Challenges@CancerGrand·Oct 13

Challenge update: extrachromosomal DNA 🧬 New findings from team eDyNAmiC, published in #NatureGenetics (@NaturePortfolio), show that where ecDNA sits in the cell can limit its power. This could open new avenues for therapies to exploit this weakness, to slow tumour growth and improve outcomes for patients with some of the most aggressive cancers. The work was led by three early career researchers: Lotte Brückner, Robin Xu and Jun Tang, in the labs of @anton_gh (@MDC_Berlin), Paul Mischel and @HowardYChang (@StanfordMed). In our latest news article, Lotte talks about her career so far, coordinating more than 60 co-authors, and where she was when she heard the paper was accepted. 👉 Read the full story: bit.ly/3VIhKpe

2:10
Anton Henssen avatar
Anton Henssen@anton_gh·Sep 14

Very happy to share our new Perspective in Nature Reviews Genetics, led and written primarily by my colleague Liam P. Shaw: “The shared evolutionary capacities of plasmids and extrachromosomal DNA” nature.com/articles/s41576-0…

Cancer Grand Challenges avatar
⟳ Anton Henssen retweeted
Cancer Grand Challenges@CancerGrand·Aug 25

📢 New 2027 conference announced! Building on the success of our inaugural conference in 2025, the second edition of the Cancer Grand Challenges Conference: Extrachromosomal DNA (ecDNA) will return from 22-24 June 2027 at @royalsociety in London. Stay tuned for speaker and programme announcements, and register your interest today ➡️ bit.ly/4wGXrFz

Post attachmentPost attachment
Anton Henssen avatar
Anton Henssen@anton_gh·12 Nov 2024

Very excited to contribute to this conference on ecDNA ! Anyone interested in this topic should register 👇🏻👇🏻🔥🔥

Next June, join us at the #CancerGrandChallenges Conference: extrachromosomal DNA 📢 We're thrilled to announce the first edition in our new conference series, where we'll be convening researchers from around the globe to discuss ecDNA. Learn more 👉 bit.ly/4evoVod

Post attachment
Stefano Santaguida avatar
⟳ Anton Henssen retweeted
Stefano Santaguida@SteSantaguida·7 Nov 2024

We are very excited to open the registration for the upcoming @EMBOevents on Chromosome Segregation and Aneuploidy in beautiful Stresa!!! You can find all the relevant info at meetings.embo.org/event/25-a… Hope to see many of you in a few months!! 🧬🔬😍 #ChromoPloidy25

Anton Henssen avatar
Anton Henssen@anton_gh·6 Nov 2024

Three papers and the cover of @Nature on ecDNA !!! 🔥🔥 What an amazing achievement by our @CancerGrand team eDyNAmiC led by @mischellab @HowardYChang @CharlesSwanton @MariamJHanjani @cbailey_58 @kinglhung and many more !!! 👏🏻👏🏻👏🏻👏🏻🍾🍾🍾🍾 Much more to come soon.

Today #CancerGrandChallenges team eDyNAmiC and their international collaborators published 3️⃣ papers in @Nature 📣 They show the prevalence of ecDNA in cancer, identify fundamental mechanisms and an actionable target now being tested in the clinic. More: bit.ly/4dUMU00

Post attachment
Elena Vasileva avatar
⟳ Anton Henssen retweeted
Elena Vasileva@EVasilevaSci·30 Oct 2024

1/4 Our @biorxivpreprint, 'Origin of Ewing Sarcoma by Embryonic Reprogramming of Neural Crest to Mesoderm' is now available on bioRxiv! In this study, we explore the enigmatic origin of Ewing sarcoma using our zebrafish genetic cancer models. We revealed that neural crest cells can uniquely tolerate EWSR1::FLI1 expression, leading to tumor formation in vivo. A big thanks to our collaborators @clairearataphd and @CrumpLab for this adventurous journey! #NeuralCrest #cancer #EwingSarcoma #zebrafish @amatrudalab @ChildrensLA @biorxiv_cancer👉biorxiv.org/content/10.1101/…

0:29